INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09969 INNOCARE

Market Closed 05-15 16:09:05

12.450

-0.320

-2.51%

High12.770	Low12.230	Vol9.68M
Open12.770	D1 Closing12.770	Amplitude4.23%
Mkt Cap21.94B	Tradable Cap18.60B	Total Shares1.76B
T/O120.06M	T/O Rate0.65%	Tradable Shares1.49B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"INNOCARE","latestPrice":12.45,"timestamp":1778832545010,"preClose":12.77,"halted":0,"volume":9683000,"delay":0,"changeRate":-0.025058731401722812,"floatShares":1494000000,"shares":1762000000,"eps":0.38,"marketStatus":"Market Closed","change":-0.32,"latestTime":"05-15 16:09:05","open":12.77,"high":12.77,"low":12.23,"amount":120060246,"amplitude":0.042287,"askPrice":12.45,"askSize":64000,"bidPrice":12.42,"bidSize":46000,"shortable":3,"etf":0,"ttmEps":0.469,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":7,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":12.77,"openAndCloseTimeList":[[1778808600000,1778817600000],[1778821200000,1778832000000]],"volumeRatio":1.2033755660217387,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"Innocare Pharma Limited","latestPrice":25.18,"timestamp":1778828400000,"preClose":25.7,"halted":0,"volume":8986200,"delay":0,"premium":"-57.01"}},"requestUrl":"/m/hq/s/09969/wiki","defaultTab":"wiki","newsList":[{"id":"2635678612","title":"InnoCare Pharma Unit Doses First Patient in Autoimmune Disease Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2635678612","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635678612?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:06","pubTimestamp":1778670400,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Ltd.  unit InnoCare Pharma Inc. dosed the first subject in a phase 1 trial of ICP-054 in China.Preclinical data shows the potential of ICP-054 to be a differentiated oral therapy for autoimmune and inflammatory diseases associated with dysregulated IL-17 signaling, according to a Wednesday Hong Kong bourse filing.The Hong Kong-listed drugmaker is developing the drug in partnership with Zenas BioPharma.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09969","BK1161","BK0239","BK1574","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149280129","title":"InnoCare and Zenas BioPharma Dose First Subject in Phase 1 Study of Oral IL-17AA/AF Inhibitor ICP-054","url":"https://stock-news.laohu8.com/highlight/detail?id=1149280129","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149280129?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:03","pubTimestamp":1778670215,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited (InnoCare) announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial evaluating ICP-054 (ZB021), a novel oral IL-17AA/AF inhibitor being...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185848254","title":"Innocare Announces First Patient Dosed in Phase 1 Trial for Oral IL-17 Inhibitor ICP-054 (ZB021)","url":"https://stock-news.laohu8.com/highlight/detail?id=1185848254","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185848254?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:50","pubTimestamp":1778669439,"startTime":"0","endTime":"0","summary":"Innocare (09969) announced that the first participant has been dosed in the Phase 1 clinical trial for ICP-054 (ZB021), a novel oral, potential best-in-class IL-17AA/AF inhibitor. ICP-054 is a new,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0239","BK1574","09969","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634640513","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Pullback","url":"https://stock-news.laohu8.com/highlight/detail?id=2634640513","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634640513?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:31","pubTimestamp":1778477471,"startTime":"0","endTime":"0","summary":"Recent performance snapshot\nInnoCare Pharma (SEHK:9969) has drawn investor attention after its shares closed at HK$13.51. The stock was down 3% over the past day and 11% over the past month, but up over the past 3 months.\nSee our latest analysis for InnoCare Pharma.\nThat recent pullback fits into a mixed picture, with the share price up 8.08% year to date and the 1-year total shareholder return at 40%, while the 5-year total shareholder return has been weaker.\nIf you are weighing what else...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09969","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633017353","title":"Is It Time To Reassess InnoCare Pharma (SEHK:9969) After Its Strong One-Year Share Price Gain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2633017353","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633017353?lang=en_us&edition=fundamental","pubTime":"2026-05-08 01:54","pubTimestamp":1778176475,"startTime":"0","endTime":"0","summary":"If you are wondering whether InnoCare Pharma's current share price really reflects its potential, the starting point is understanding how the stock stacks up on value.\nThe share price closed at HK$13.93 with returns of 0.7% over 7 days, a 10.2% decline over 30 days, an 11.4% gain year to date, and a 44.5% gain over 1 year. This gives useful context before comparing this to longer term figures like the 46.9% 3 year return and the 34.4% 5 year decline.\nRecent company developments and market...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/is-it-time-to-reassess-innocare-pharma-sehk9969-after-its-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/is-it-time-to-reassess-innocare-pharma-sehk9969-after-its-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1574","BK1161","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166105738","title":"InnoCare Pharma Maintains Stable Share Capital in April; 14.04 Million Shares Remain under Incentive Schemes","url":"https://stock-news.laohu8.com/highlight/detail?id=1166105738","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166105738?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:44","pubTimestamp":1778143441,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited reported no changes to its share capital structure for April 2026, according to the company’s Monthly Return submitted to Hong Kong Exchanges and Clearing Limited on 7 May...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116977360","title":"INNOCARE Shares Rise Nearly 3% on ASCO 2026 Oral Presentation Selection for Mesutoclax Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1116977360","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116977360?lang=en_us&edition=fundamental","pubTime":"2026-04-28 09:56","pubTimestamp":1777341385,"startTime":"0","endTime":"0","summary":"INNOCARE (09969) saw its shares increase by nearly 3%. At the time of writing, the stock was up 2.67%, trading at HK$14.24 with a turnover of HK$29.20 million. The movement follows an announcement...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1574","BK4588","09969","BK4585","BK1161","BK0239","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630664033","title":"A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum And Analyst Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2630664033","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630664033?lang=en_us&edition=fundamental","pubTime":"2026-04-27 13:07","pubTimestamp":1777266466,"startTime":"0","endTime":"0","summary":"What recent performance says about InnoCare Pharma\nInnoCare Pharma (SEHK:9969) has caught investor attention after a 4.4% move in the latest session, alongside a mixed pattern over the past week, month and past 3 months that highlights shifting sentiment toward the stock.\nOver the past week the share price shows a 6.5% decline, while the past month return sits at 12.1% and the past 3 months at 26.4%. Year to date the stock is up 17.6%, with a 1 year total return of 44.97% and a 3 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/a-look-at-innocare-pharma-sehk9969-valuation-after-recent-sh-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630291385","title":"InnoCare Pharma Limited Just Missed Revenue By 19%: Here's What Analysts Think Will Happen Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2630291385","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630291385?lang=en_us&edition=fundamental","pubTime":"2026-04-26 08:50","pubTimestamp":1777164630,"startTime":"0","endTime":"0","summary":"Last week, you might have seen that InnoCare Pharma Limited ( HKG:9969 ) released its first-quarter result to the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-limited-just-missed-revenue-by-19-heres-what","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/innocare-pharma-limited-just-missed-revenue-by-19-heres-what","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167024959","title":"INNOCARE Calls 16 June AGM to Vote on 2026 Share Incentive Scheme, RSU Grants and Governance Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=1167024959","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167024959?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:43","pubTimestamp":1777041829,"startTime":"0","endTime":"0","summary":"INNOCARE will hold its annual general meeting on 16 June 2026 in Beijing. Shareholders will review the 2025 Annual Report, which recorded operating revenue of RMB 2.37 billion and the first full-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199481869","title":"Innocare Awards 15.39 Million Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1199481869","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199481869?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:27","pubTimestamp":1777037253,"startTime":"0","endTime":"0","summary":"Innocare (09969) announced that on April 24, 2026, the company granted 15.3892 million restricted share units under the 2023 Equity Incentive Plan to three grantees. These units represent...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09969","BK0239","688428"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198970011","title":"InnoCare issues 15.39 million RSUs; executive portion subject to AGM vote","url":"https://stock-news.laohu8.com/highlight/detail?id=1198970011","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198970011?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:24","pubTimestamp":1777037060,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced that on 24 April 2026 the board approved a grant of 15.39 million restricted share units (RSUs), equal to about 0.87 % of issued shares (excluding treasury stock),...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176300554","title":"Stock Track | INNOCARE Soars 5.11% Intraday on Stellar Q1 2026 Results with 489% Net Profit Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1176300554","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176300554?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:35","pubTimestamp":1776998137,"startTime":"0","endTime":"0","summary":"INNOCARE's stock price surged 5.11% during intraday trading on Friday, reflecting strong investor sentiment following the release of the company's latest financial performance.The significant price...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160384501","title":"Carbon Peak and Carbon Neutrality Evaluation Measures Released; Innocare Q1 Net Profit Surges 488.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160384501","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160384501?lang=en_us&edition=fundamental","pubTime":"2026-04-24 07:27","pubTimestamp":1776986822,"startTime":"0","endTime":"0","summary":"China's General Office of the Communist Party of China Central Committee and the General Office of the State Council have jointly issued the \"Comprehensive Evaluation and Assessment Measures for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1513","BK0239","BK1568","BK4585","09969","LU1808992512.USD","BK4588","00148","BK1175","VXUS","159790","BK1170","BK1592","688428","02600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183810232","title":"创新药企InnoCare 2025年度业绩显著提升，首度实现盈利并拓展多元业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1183810232","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183810232?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:07","pubTimestamp":1776942478,"startTime":"0","endTime":"0","summary":"2025年，InnoCare业绩呈现大幅增长，全年营业收入约23.749亿元（人民币，下同），较2024年的10.094亿元同比上升135.3%，并实现上市以来的首次年度盈利，净利润约6.442亿元，相比上一年度亏损4.529亿元出现明显反转。管理层表示，这一表现主要来自于在研及在售产品的商业化推进、多项全球业务合作的收入确认，以及布局血液肿瘤、自身免疫疾病与实体瘤等多个治疗领域的综合带动。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"创新药企InnoCare 2025年度业绩显著提升，首度实现盈利并拓展多元业务布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169828632","title":"INNOCARE 2025 ESG Report: First-Time Profit, RMB 951.60 Million R&D Outlay and 60.75 % Carbon-Intensity Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=1169828632","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169828632?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:06","pubTimestamp":1776942388,"startTime":"0","endTime":"0","summary":"INNOCARE released its 2025 Environmental, Social and Governance (ESG) Report, outlining the group’s first year of profitability, significant environmental gains and continued investment in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157412736","title":"InnoCare Pharma Q1 2026: Net Profit Jumps 4.9-Fold on 45% Drug-Sales Surge, Cash Pile Tops 7.92 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1157412736","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157412736?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:05","pubTimestamp":1776942327,"startTime":"0","endTime":"0","summary":"InnoCare Pharma released its unaudited first-quarter 2026 results, highlighting a sharp turnaround in profitability on the back of strong product demand and milestone income. Revenue and Earnings   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180322339","title":"Xie Zhiyu's Q1 Portfolio Revealed: Increased Bets on Chemical and Energy Storage Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1180322339","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180322339?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:53","pubTimestamp":1776779624,"startTime":"0","endTime":"0","summary":"Prominent fund manager Xie Zhiyu has disclosed his first-quarter portfolio holdings. Taking the Xingquan Herun Mixed Fund as an example, Xie executed a clear sector rotation strategy during the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326948709.USD","LU1642822792.SGD","LU0868486357.SGD","LU0577902298.EUR","LU0588546209.SGD","SGXZ90724238.SGD","LU0196878994.USD","LU0499858438.USD","LU0650527681.SGD","LU2039709279.SGD","LU0499858602.USD","BK1608","LU1997245094.SGD","LU1316542783.SGD","LU0211977185.USD","LU0828238088.HKD","LU1044875133.USD","LU0011963245.USD","LU0149721374.USD","LU1102505929.USD","LU1810669033.SGD","LU0762542818.HKD","BK1589","LU0165289439.USD","IE0008368304.USD","LU0823039010.USD","LU1048484197.HKD","BK1591","LU0328353924.USD","LU0261950470.USD","LU0348783662.USD","LU0634319403.HKD","LU0873338254.USD","SG9999006514.SGD","LU2399975544.HKD","LU0456846285.SGD","LU0477156797.USD","LU0890818403.SGD","BK0167","LU0132412106.USD","LU0737861772.HKD","LU0061477393.USD","SG9999001226.SGD","LU0708995583.HKD","HK0000181138.USD","LU0054237671.USD","LU2275660780.HKD","LU1794554557.SGD","LU1282651048.USD","LU1366334578.USD","SGXZ81163826.USD","LU2289578879.USD","LU2106854487.HKD","LU2580892789.USD","ALBmain","LU0169518387.USD","BK1583","LU0269904917.USD","LU2249611893.SGD","LU0589944569.HKD","LU0312595415.SGD","LU0449509016.USD","002008","LU1956131251.USD","IE0034224299.USD","LU0823414478.USD","LU0210527791.USD","LU0192582467.USD","LU0588545490.SGD","IE00B0169N27.USD","SG9999000327.SGD","IE00B8L5B284.USD","LU0762541174.USD","LU0043850808.USD","IE00BZ08YT58.USD","LU0348784397.USD","LU1655091616.SGD","LU0784639295.USD","LU1255011170.USD","LU1196710864.SGD","LU0502904849.HKD","LU1808992512.USD","LU3063872942.SGD","LU0047713382.USD","LU0348825331.USD","LU0516422952.EUR","SG9999001846.SGD","BK1575","LU2506952253.HKD","LU0979878070.USD","LU0197773673.USD","LU0417516738.SGD","LU2348773727.SGD","LU0607220059.USD","LU1993786604.SGD","LU0823413660.USD","LU1064130708.USD","LU0501845795.SGD","LU2357125470.USD","LU0620787316.HKD","LU1721428347.USD","LU1201861165.SGD","SG9999001689.USD","LU0862451753.SGD","LU1880398471.USD","LU2360107325.USD","LU0588545904.SGD","LU2506951792.HKD","LU0823040885.USD","LU0516423174.USD","LU0823426308.USD","HK0000107257.USD","BK1610","LU0762540952.USD","LU2580892862.HKD","HK0000306701.USD","BK0152","LU2360108059.USD","LU2125910849.SGD","LU0700851271.USD","HK0000165453.HKD","LU0577902538.SGD","LU1997244956.HKD","LU0348783233.USD","LU0791590937.USD","LU0516422440.USD","LU1974910355.USD","LU2153591404.USD","SG9999014674.SGD","LU0164865239.USD","LU0048580855.USD","SG9999002828.SGD","600160","LU2298321311.HKD","BK1521","LU0197773160.USD","LU1719994722.HKD","LU0572940350.SGD","LU0173614495.USD","LU0320764243.SGD","LU0235996351.USD","LU1504937902.USD","LU0130518102.USD","LU0261950983.USD","LU0605514214.HKD","LU0463099449.HKD","LU1023057109.AUD","LU2488822045.USD","LU2041044095.USD","LU0828237940.HKD","LU1323998911.USD","LU2476274308.USD","BK1502","09988","BK1097","LU1568876251.USD","LU0543330566.HKD","LU0326950275.SGD","LU1146622755.USD","LU0648000940.SGD","IE00BZ199S13.USD","LU1934453819.USD","LU0821914370.USD","LU0348805143.USD","LU0509642566.USD","LU2294711473.HKD","LU0082770016.USD","LU0029875118.USD","LU1048588211.SGD","LU0096374516.USD","LU1548497426.USD","BK0015","LU1152091754.HKD","SGXZ86797644.SGD","BK1161","LU0264606111.USD","LU0128522157.USD","LU0140636845.USD","LU0048597586.USD","LU0823038988.USD","LU1720051017.SGD","IE00BZ08YS42.EUR","BK0188","IE00B0JY6N72.USD","LU2097829019.USD","LU2778985437.USD","LU0287142896.SGD","LU0823426480.USD","LU0823397285.USD","LU0577902611.USD","LU0315178854.USD","LU0819121731.USD","LU0261947096.USD","IE00B8HQ1Z84.USD","SG9999002463.SGD","BK0061","LU0188438112.USD","LU0593848301.USD","LU0561508036.HKD","LU0345776255.USD","BK0066","LU1282649141.HKD","01801","LU0359202008.SGD","BK0224","LU0314109678.HKD","LU0516422366.SGD","688099","SGXZ62798434.SGD","IE0032431581.USD","LU0072913022.USD","LU0724618433.USD","LU0898667661.SGD","IE00BMPRXR70.SGD","IE00B3M56506.USD","605117","LU0164872284.USD","SG9999004220.SGD","LU0675040207.SGD","LU2213484517.USD","SG9999000459.SGD","03750","LU2298322129.HKD","LU0651946864.USD","LU0067412154.USD","LU0054450605.USD","LU0588545730.USD","LU1211504680.USD","LU0107464264.USD","LU0254981946.USD","LU0441854154.USD","LU1655091459.SGD","LU0228659784.USD","LU1366334651.USD","LU1868837565.USD","LU0456827905.SGD","89988","LU2153592121.USD","LU0594300179.USD","LU0210526637.USD","LU1188198961.HKD","IE00BMPRXN33.USD","BK1249","LU0049853897.USD","LU0259732245.USD","SG9999001093.SGD","LU0163747925.USD","000683","LU1048596156.SGD","IE0003851619.USD","LU0214875030.USD","BK1588","LU1115378108.SGD","LU0348827113.USD","IE00BYQNZ168.SGD","LU1051768304.USD","LU1064131003.USD","BABA","LU0831103253.SGD","LU0143863784.USD","LU1770034418.SGD","LU2045819591.USD","LU1224709979.USD","LU2449936058.SGD","LU2097828631.EUR","LU0149534421.HKD","HK0000151867.HKD","BK1517","LU1961090484.USD","BK0028","SG9999001051.SGD","LU1152091168.USD","BK0201","LU0672654166.SGD","LU0124384867.USD","LU0048575426.USD","LU0130103400.USD","LU0417516571.SGD","LU0128522744.USD","LU2023250504.SGD","LU0164880469.USD","LU0540923850.HKD","LU0505663152.USD","LU1481107354.HKD","LU2087589342.USD","LU1969619763.USD","BK1615","SG9999003461.SGD","LU1820825898.SGD","LU1831875114.USD","LU0611395673.USD","LU0831093199.SGD","LU2476274720.SGD","BK1586","HK0000320264.USD","BK0073","LU0531971595.HKD","LU0828237510.HKD","LU0608807433.USD","LU1439103000.SGD","LU0823437842.USD","LU2097828557.USD","LU0072462343.USD","LU0516423091.SGD","LU0293314216.USD","BK1142","LU1939255532.USD","LU0302445910.USD","LU1770036033.HKD","LU0359201612.USD","LU0886674414.USD","LU1515016050.SGD","IE00B12V2V27.USD","LU0630378692.HKD","LU0228367735.SGD","LU0871576103.HKD","LU2242644610.SGD","LU0127658192.USD","600426","LU0531970944.HKD","LU0819123356.HKD","LU0823041008.USD","LU0396098781.USD","LU0469268626.HKD","LU0315179316.USD","LU1282651121.HKD","LU0791591158.USD","LU1568876335.HKD","LU1580142542.USD","LU1044874839.SGD","LU2092937221.SGD","LU0052750758.USD","LU0880133367.SGD","LU0737861699.HKD","LU0348788117.USD","LU1868838027.USD","IE0003795394.USD","BK0214","LU0106259558.USD","LU2257852520.SGD","LU0106252389.USD","LU0572939691.SGD","BK1574","BK0064","HK0000306685.HKD","LU0648948544.HKD","SG9999002562.SGD","LU1242518931.SGD","LU0117844026.USD","LU1328615791.USD","LU0084288322.USD","LU1979443071.USD","LU0143863198.USD","IE00B543WZ88.USD","HK0000320223.HKD","LU1880383440.USD","LU1997245177.USD","LU1880383366.USD","LU0823413587.USD","LU0405327494.USD","300308","BK0077","LU1880398554.USD","LU0329678170.USD","LU2294711713.HKD","LU1978683503.SGD","LU0117841782.USD","LU1813983027.USD","LU0577902454.USD","LU2477742899.HKD","LU0329678337.USD","LU0541501648.USD","LU0251144936.SGD","SG9999011746.SGD","688008","BK1501","LU0320764599.SGD","LU0307460666.USD","LU1242518857.USD","BK1116","LU2348774022.SGD","LU0251143458.SGD","LU0488056044.USD","LU1917777945.USD","LU0577902371.SGD","LU1960683339.HKD","LU0856984785.SGD","LU1224444064.USD","LU2097828474.EUR","LU1769817096.USD","LU1303224171.USD","LU0862451837.USD","LU0231483743.USD","02423","LU1282649067.USD","BK0251","IE00BYTNYN87.SGD","LU2298064838.USD","LU0541502299.USD","LU0640798160.USD","LU1720050803.USD","LU2148510915.USD","LU0594300419.USD","LU0417516902.SGD","LU0608807946.USD","LU1981816686.USD","LU0244354667.USD","LU2097828714.EUR","LU0370786039.SGD","IE00BPRC5H50.USD","LU1102505762.USD","LU2424517915.HKD","LU0823397103.USD","LU0082770016.SGD","LU0320764755.SGD","HBBD.SI","BK0196","BK0187","LU2328871848.SGD","LU1328277881.USD","BK0231","HK0000181112.HKD","LU0865486749.SGD","LU0345775950.USD","HK0000286598.CNH","BK1618","LU1051769294.HKD","LU1861214812.USD","LU0708995153.HKD","LU2097828805.USD","LU2357305700.SGD","LU1251922891.USD","LU2238339852.HKD","IE0003895053.USD","LU2152927971.USD","BK0229","688120","LU0181495838.USD","LU0051755006.USD","LU0039217434.USD","LU0572944931.SGD","IE00BD6J9T35.USD","SG9999001903.USD","LU0164939612.USD","LU2495084118.USD","BK1584","LU1781817850.SGD","LU2125910500.SGD","LU0455707207.USD","BK0072","LU0456842615.SGD","LU1008478684.HKD","SGXZ49509284.SGD","BK0044","BK0070","LU0048388663.USD","LU1282649810.SGD","LU0229945570.USD","LU0651947912.USD","LU1039395188.USD","LU0359201885.HKD","LU0543330483.HKD","LU0029874905.USD","LU2506952410.USD","LU2506952337.HKD","LU0630378429.USD","LU0642271901.SGD","LU1044876610.USD","09969","LU0106959298.USD","EVS.SI","LU0348735423.USD","IE00B5MMRT66.SGD","SG9999006597.SGD","LU0405327148.USD","LU0384037296.USD","LU2394011477.USD","IE00B29SXG58.USD","LU0327786744.USD","300750","IE00BZ08YR35.GBP","LU1807302812.USD","LU1688375341.USD","LU0431992006.USD","LU0823414551.USD","LU1720051108.HKD","LU1769817179.HKD","LU1861219969.SGD","LU0449515922.USD","LU2293587155.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134446676","title":"InnoCare Pharma Sets 23 April Board Meeting to Approve Q1 2026 Unaudited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1134446676","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134446676?lang=en_us&edition=fundamental","pubTime":"2026-04-10 17:22","pubTimestamp":1775812956,"startTime":"0","endTime":"0","summary":"InnoCare Pharma Limited announced that its Board of Directors will convene on 23 April 2026 to review and approve the unaudited consolidated results for the three-month period ended 31 March 2026....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625299010","title":"Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2625299010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625299010?lang=en_us&edition=fundamental","pubTime":"2026-04-08 11:24","pubTimestamp":1775618675,"startTime":"0","endTime":"0","summary":"Earnings shift draws fresh attention to InnoCare Pharma\nInnoCare Pharma (SEHK:9969) has drawn fresh attention after reporting full year 2025 sales of CN¥2,374.91 million and net income of CN¥642.47 million, compared with a net loss a year earlier.\nSee our latest analysis for InnoCare Pharma.\nThe earnings swing has coincided with strong price momentum, with a 31.19% 1 month share price return and a 24.16% year to date share price return at HK$15.52. The 1 year total shareholder return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/assessing-innocare-pharma-sehk9969-valuation-after-its-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9969/innocare-pharma-shares/news/assessing-innocare-pharma-sehk9969-valuation-after-its-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09969","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":-0.0785},{"period":"1month","weight":-0.1999},{"period":"3month","weight":-0.0166},{"period":"6month","weight":-0.1793},{"period":"1year","weight":0.2875},{"period":"ytd","weight":0.0122}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":0.0006},{"period":"3month","weight":-0.0227},{"period":"6month","weight":-0.0229},{"period":"1year","weight":0.107},{"period":"ytd","weight":0.013}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.010195},{"month":4,"riseRate":0.714286,"avgChangeRate":0.102464},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.050763},{"month":6,"riseRate":0.833333,"avgChangeRate":0.12939},{"month":7,"riseRate":0.5,"avgChangeRate":0.039258},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"INNOCARE","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOCARE,09969,INNOCARE股票,INNOCARE股票老虎,INNOCARE股票老虎国际,INNOCARE行情,INNOCARE股票行情,INNOCARE股价,INNOCARE股市,INNOCARE股票价格,INNOCARE股票交易,INNOCARE股票购买,INNOCARE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOCARE(09969),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOCARE(09969) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}